Page last updated: 2024-09-04

moxifloxacin and Cholangitis

moxifloxacin has been researched along with Cholangitis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bang, KB; Kim, HJ; Kim, NH	1
Huber, W; Kamereck, K; Prinz, C; Schmid, RM; Voland, P; Weber, A; Weidenbach, H; Winkle, P	1
Grauer, M; Hahn, EG; Mühldorfer, S; Schwab, D	1

Trials

2 trial(s) available for moxifloxacin and Cholangitis

Article	Year
Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2017, Oct-15, Volume: 16, Issue:5 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies	2017
Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract. Alimentary pharmacology & therapeutics, 2005, Sep-01, Volume: 22, Issue:5 Topics: Aza Compounds; Bile; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Quinolines	2005

Article

Year

Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2017, Oct-15, Volume: 16, Issue:5

Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies

2017

Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.

Alimentary pharmacology & therapeutics, 2005, Sep-01, Volume: 22, Issue:5

Topics: Aza Compounds; Bile; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Quinolines

2005

Other Studies

1 other study(ies) available for moxifloxacin and Cholangitis

Article	Year
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. World journal of gastroenterology, 2008, May-28, Volume: 14, Issue:20 Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bile; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Male; Middle Aged; Moxifloxacin; Piperacillin; Prospective Studies; Quinolines; Sulbactam	2008

Article

Year

In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.

World journal of gastroenterology, 2008, May-28, Volume: 14, Issue:20

Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bile; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Male; Middle Aged; Moxifloxacin; Piperacillin; Prospective Studies; Quinolines; Sulbactam

2008